Julie Rubinstein, President at Adaptive Biotechnologies Corp (ADPT), sold 45,336 shares at $8.57 ($389K) on 2023-03-06, disclosed to the SEC on 2023-03-08.
Open-market sale of $389k ADPT by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.57 | 22,668 | $194K | 50.0% |
| 2 | $8.57 | 22,668 | $194K | 50.0% |
| Total | $8.57 avg | 45,336 | $389K | 100% |
| Filing → |
| ADPT | SELL | 2026-10-05 | $1.0M | — | Filing → |
| ADPT | SELL | 2026-04-29 | $271K | — | Filing → |
| ADPT | SELL | 2026-04-24 | $798K | — | Filing → |